一種全自動(dòng)診斷免疫檢測(cè)方法能夠檢測(cè)人血清和血漿中是否存在人類免疫缺陷病毒(HIV)。

Bayer健康保健診斷部(Tarrytown, New York, USA)是Bayer集團(tuán)成員，今天宣布全自動(dòng)檢測(cè)EHIV(人類免疫缺陷病毒，增強(qiáng)型)已經(jīng)獲得了美國(guó)食品藥品管理局(FDA)關(guān)于Advia Centaur免疫檢測(cè)系統(tǒng)的批文。Advia Centaur EHIV是一種全自動(dòng)檢測(cè)，包括一系列重組蛋白和亞型O蛋白能夠檢測(cè)HIV-1、HIV-2和亞型O肽。能夠滿足全球范圍內(nèi)檢測(cè)所有已知類型HIV感染的標(biāo)準(zhǔn)。

 
 
Automated Test Detects HIV Antibodies
 
A fully automated diagnostic immunoassay determines whether antibodies to the human immunodeficiency virus (HIV) are present in human serum and plasma.

Bayer HealthCare Diagnostics Division (Tarrytown, New York, USA) a member of the Bayer Group, today announced that the fully-automated test called EHIV (human immunodeficiency virus, enhanced), has received U.S. Food and Drug Administration (FDA) approval for use on the Advia Centaur immunoassay system. Advia Centaur EHIV is a fully-automated test that contains a range of recombinant proteins and sub-type O peptide for the detection of antibodies to HIV-1, HIV- 2, and sub-type O peptide. This meets the worldwide healthcare standards for detecting all known types of HIV infection.